Food Poisoning Treatment in Adults
Rehydration, norovirus recovery, what to eat, medicine cautions, and when to seek urgent care.
Health Guides · 154 and counting
Symptoms, treatment, and when to get seen, explained the way a physician explains them in the exam room. Every source cited.
Last 90 days, by search traffic
Changes monthly
No guides match .
Try a broader term, or tell us what you were looking for and it may become the next guide.
Nothing saved yet.
Tap the bookmark on any guide to keep it here. Saved guides stay on this device only.
Bites, infections, pain, respiratory, and other same-day concerns.
Rehydration, norovirus recovery, what to eat, medicine cautions, and when to seek urgent care.
Why cat bites infect at 30-50% rates, Pasteurella multocida urgency, antibiotic prophylaxis, hand-bite dangers, and Kanavel signs.
Exact regimen, tapering rules, why short courses are dangerous, and Medrol Dosepak pitfalls.
Topical vs systemic steroids, why creams often fail, and when prednisone is the right call.

Post-exposure prophylaxis evidence and how it compares to Paxlovid.
Live CDC/FDA case tracker, the stool test standard panels miss, and the antibiotic that cures it.

2026 clinical updates on POTS, exercise pacing, and what current evidence supports.

Updated allergist recommendations and what changed.
Wound care, when antibiotic prophylaxis is warranted, rabies risk, and when to head to the ED.

Latest data on effectiveness in vaccinated adults.
The virus, the five stages, oral versus topical antivirals, the 24-hour timing window, and suppression.
Intraoral herpes, gingivostomatitis in kids, and how to distinguish these from canker sores.
The five stages from tingle to healing, how long each lasts, and when you are most contagious.
How to tell the two apart and why the treatment for each is different.
The timing window, the best oral antivirals, and what home care actually does.
The one-day 2-gram regimen, how the prodrug works, timing, side effects, and telehealth access.
The 72-hour rule, exceptions, and what happens if you miss it.
First-line antibiotics, when IV therapy is required, MRSA coverage, and abscess vs cellulitis.
Antiviral window, pain control, and when postherpetic neuralgia develops.
Viral vs bacterial, 10-day rule, antibiotic indications, and symptomatic care.
Strep vs viral, Centor criteria, when to test, and treatment options.
Bridging treatment while you get to a dentist, when antibiotics matter, and red flags.
Treatment eligibility, dosing, drug interactions, and rebound COVID.
Adult otitis media, treatment options, and when watchful waiting is safe.
Scopolamine patches, meclizine timing, and prevention that works.
Antihistamines, nasal steroids, and when allergy testing helps.
Antiviral windows, testing, symptom management, and when to seek care.
Who needs it, timing, side effects, and cost.
Rapid vs PCR, home tests, and when a positive changes management.
Triptans, gepants, prevention, and when imaging is needed.

The evidence for skipping antibiotics in adult conjunctivitis.
When and how to use it, storage, and what happens after you inject.
Bacterial vs viral vs allergic, when antibiotics help, and return-to-work rules.
Regional guide for smoke exposure, inhalers, and remote-triage decisions.
Acute flare treatment, urate-lowering therapy, and diet reality checks.
One lowers urate, the other stops a flare. Why they are usually prescribed together.
Colchicine, NSAID, or steroid: dosing, ice, and how fast each option works.
Beer, sugar, and high-purine foods ranked by gout risk, plus what actually helps.
Two crystals, two diseases: how urate gout differs from calcium pyrophosphate disease.
The 6.8 mg/dL threshold, what counts as high, and the 6.0 treatment target.
What AQI really means, which masks work, the $50 DIY air purifier, and ER red flags.
Identifying triggers, topical steroid ladder, and when to escalate to oral steroids.
Oseltamivir, baloxavir, timing windows, and who benefits.
Controller vs rescue inhalers, action plans, and when to escalate.
When to test, antiviral eligibility, and high-risk patient decisions.
What is normal, what is not, and separating vaccine reactions from unrelated illness.
Topical vs oral antibiotics, contagion control, and when to swab.
Continued breastfeeding, when antibiotics help, and abscess red flags.
Tick removal, Lyme prophylaxis criteria, single-dose doxycycline, and rash monitoring.

When abscesses need antibiotics vs immediate dental drainage.
Topical steroids, amlexanox, magic mouthwash, B12, and when a recurrent ulcer needs a workup.
Rashes, eczema, acne, and dermatology conditions treatable via telehealth.
Antihistamines, the 24-hour wheal and 6-week rule, prednisone evidence, and emergency signs.
Topical vs oral antifungals, and how to prevent household spread.
Permethrin, ivermectin, household treatment, and post-treatment itching.
Zinc, ketoconazole, selenium sulfide, and rotation strategy.
Primary vs secondary, workup, and treatment ladder.
OTC vs prescription options, resistance, and non-medicated methods.
Topicals, phototherapy, biologics, and when to see a dermatologist.
Topical retinoids, antibiotics, isotretinoin, and hormonal options.
Moisturizer strategy, topical steroid ladder, and newer biologics.
Concentration, cycling, safety concerns, and OTC alternatives.
Sunscreen, hydroquinone, tretinoin, and why it comes back.
Why you must stop the steroid cream, and what actually works.
Azelaic acid 10% vs 15%, gel vs foam, irritation, and feature-based rosacea treatment.
Why the pigment changes linger, and treatment that actually clears it.
How to recognize it, when to taper, and evidence on management.
STI testing, treatment, and prevention with evidence-based sourcing.
Which test, when, and where: CDC and USPSTF screening, home vs clinic collection, and choosing a panel.
Topical treatments, cryotherapy, HPV vaccination, and recurrence.
Episodic vs suppressive antivirals, disclosure, and transmission risk.
Doxycycline first-line, azithromycin exceptions, partner treatment, and retest window.
CDC recommendation, dosing, who qualifies, and resistance concerns.
Causes, symptoms, CDC treatment, and stopping recurrent BV.
The biofilm evidence, a typical protocol, and the safety rules.
What BV discharge looks like and how it differs from yeast and trich.
Why BV smells fishy, the whiff test, and how to stop the odor.
pH, discharge, and odor clues that tell the two apart.
Treatment and the evidence-backed ways to stop it coming back.
Uses, alcohol interaction reality, and side effect management.
Metronidazole dosing changes and partner treatment.
Symptoms, causes, fluconazole and OTC treatment, and recurrent infections.
Dosing, effectiveness, safety, and when the single 150 mg pill stops working.
Why infections return and the suppression treatments, including oteseconazole.
Symptoms, causes, and risk factors, and how the diagnosis is confirmed.
What actually works, from boric acid to the remedies to skip.
How to tell the two apart: pH, discharge, odor, and the right treatment.
Long-term conditions, medication refills, and ongoing management.
PPI vs H2, lifestyle, and when to escalate.
SSRI/SNRI selection, timing, and what to expect the first six weeks.
What can be prescribed via telehealth and what needs an in-person visit.
Statin eligibility, PCSK9 inhibitors, and diet realism.
Treatment thresholds, first-line medications, and home monitoring.
Home care, when procedures help, and red flags to rule out.
Levothyroxine dosing, T3 debate, and monitoring cadence.
Metformin, GLP-1s, SGLT2s, and the modern treatment ladder.
Hormonal, reproductive, and gender-specific care.
Cognitive strategies, PDE5s, SSRIs, and when to escalate care.

What changed in the 2026 guideline and what it means for treatment.
Prevention evidence vs treatment claims.
Alpha-blockers, 5-ARIs, combination therapy, and 2026 AUA updates.
Non-hormonal, local estrogen, and safety in cancer survivors.
2025 IDSA guideline changes, first-line antibiotics, and recurrence prevention.
When a UTI becomes an ED-level concern.
PDE5 inhibitors, cardiovascular workup, and when testosterone helps.
Differential, when to test, and what treatment usually looks like.
Classic vs atypical presentations and when to test vs treat empirically.
What phenazopyridine does, does not do, and when it hides bigger problems.
Finasteride, dutasteride, minoxidil, and combination therapy.
Why male UTIs deserve a workup and what it should include.
How AI chatbots perform against physicians, hallucination rates, safety, and regulation.

Current benchmarks for fabricated citations and clinical claims.

What controlled studies show and where LLMs still fall short.

What triggered the letter and what it signals for AI medical products.

What happens when chatbots are asked about conditions that do not exist.

Safety guardrails, failure modes, and how to use these tools safely.

Active litigation, regulatory response, and clinical implications.

Evidence for AI-assisted triage of cough, congestion, and shortness of breath.
Clinical evidence for what telehealth actually does well, condition by condition.

When virtual assessment is enough and when it is not.

Store-and-forward dermatology accuracy and limitations.

Outcomes data for virtual UTI diagnosis and treatment.

Antibiotic stewardship in virtual sinus care.

Current data on antibiotic prescribing patterns in virtual care.

Outcomes for common dermatology conditions treated virtually.
Prescriptions and care for international visitors, mobile workers, and travelers.
Acetazolamide dosing, dexamethasone, and ascent strategy.

Bridge prescriptions and what telehealth can and cannot do.

DOT exam prep, chronic condition management, and on-the-road care.

Home monitoring, medication refills, and DOT-compliant control.

Common medication equivalents and Rx access.

How visitors to the US access urgent care and prescriptions.

Guía en español para acceder a atención en EE. UU.

Prescription refills and virtual care for aviation professionals.

Prescriptions, telehealth, and common conditions when your home is on wheels.

Bridge care for parents visiting adult children in the US.

US pharmacy access and prescribing rules.

How US prescriptions work for tourists and short-term visitors.
Aesthetic dermatology, weight management, and quality-of-life care.
Efficacy, side effects, and comparison to OTC serums.

What the FDA proposal means for compounded semaglutide access.
The gold standard for photoaging and acne, without the myths.

Insurance, direct primary care, and telehealth for independent workers.
Varenicline, bupropion, NRT, and combination therapy that actually works.
Oral semaglutide, orforglipron, and how they compare to injectables.

How to negotiate, verify, and reduce medical bills.
Physician-reviewed guides for parents on common childhood conditions, age-banded red flags, and school return rules.
Honest reviews of consumer home test kits and how to interpret results.
Reading results honestly and what to do next.
PCR at home for chlamydia, gonorrhea, and trichomonas.
Test strip accuracy, when a positive matters, and false negatives.
Accuracy, cost, and how it compares to in-lab testing.
Deductibles, coinsurance, medical bills, and medical debt, explained in plain language.
The numbers behind why coverage is not the same as affordability.
The percentage you pay after your deductible, with real examples and 2026 Medicare figures.
How the three cost-sharing terms differ and stack together.
The yearly cap on covered care, the 2026 limits, and how it works.
How to read an explanation of benefits, field by field.
Doctor and urgent care prices when you pay yourself.
What medical debt does to your credit after the federal rule was vacated.
Charity care: who qualifies, what hospitals must offer, and how to apply.
The step-by-step order for handling a bill you cannot afford.
Your rights under the No Surprises Act, and the ground-ambulance gap.
Clinical updates
FDA actions, guideline changes, and new trials, with what they mean for patients.
Series Week 4 of 6. The January 2026 Character.AI/Google settlements document systemic failure patterns: no escalation protocols, no age-gating, no parental notification. What the NAM panel found about adolescent susceptibility, and where supervised AI reliably helps in mental health.
Evidence assessment of Everlywell's mail-in STI panel, self-collected NAAT accuracy, dried blood spot serology performance, uptake data, what the panel covers, and dual-path next steps after a positive result.
Series Week 3 of 6. GPT-3.5 fabricates 55% of citations. Bard hallucinates 91.4% of medical references. A peer-reviewed breakdown of AI hallucination rates across models and tasks, and where verification is essential vs. where AI adds reliable value.
The 2026 evidence on antibiotic prescribing quality in virtual care, sinusitis may see less prescribing than in-person, UTI stewardship outperforms respiratory, and CDC Core Elements cut hospitalizations when implemented.
Series Week 2 of 6. Scientists invented a disease with fictional funding sources and obvious fabrication clues, then watched three major AI systems describe it as a real medical diagnosis. What the experiment reveals about AI reliability and the 12-fold rise in fabricated citations.
FDA approved ensitrelvir on May 29, 2026 for COVID-19 post-exposure prophylaxis -- the first PEP option to clear US regulatory review. The trial evidence, the dosing window, and how it differs from Paxlovid.
Series Week 1 of 6. The FDA's April 2, 2026 Warning Letter to Purolea Cosmetics is the first cGMP enforcement explicitly citing AI misuse. FDA didn't ban AI -- it required human review and quality-unit oversight. The precedent for every AI-in-healthcare deployment.
A 44-study meta-analysis shows photo-based dermatology agreement reaches 76% with proper photo standards. The evidence on which skin conditions are safely managed by image alone -- and which still need in-person dermoscopy or biopsy.
The American Urological Association just released a 62-recommendation overhaul of BPH/LUTS care: PAE upgraded to Grade B, Aquablation expanded to larger prostates, tadalafil + 5-ARI combo formalized, and HIFU/cryoablation restricted to trials.
The full editorial map of telehealth in 2026. A three-tier decision framework, evidence by category, red flags that require in-person care, and links to all 49 condition guides plus the new At-Home Testing track.
RECOVER-VITAL Paxlovid and ENERGIZE Metformin both failed as treatments in 2026 trials. Metformin still cuts Long COVID risk 41-63% when started during acute infection. Here's what the evidence supports now.
FDA's April 30 proposal would exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list. 100+ hospitalizations and 10+ deaths have been linked to compounded versions.
How these are written
These are not rewritten patient handouts. Each guide follows the evidence review and clinical judgment that go into real visits, written so a patient can follow it.
Clinical claims cite published guidelines, trials, or systematic reviews.
Checked against CDC, USPSTF, IDSA, AAD, AUA, and ACOG updates, with the review month on every guide.
No sponsored content, no affiliate links, no product endorsements.
Questions
Every guide is written and reviewed by Parth Bhavsar, MD, a board-certified family medicine physician and the founder of TeleDirectMD. They are not outsourced, ghostwritten, or generated from other websites. Each guide shows the month it was last clinically reviewed.
Guides are checked against new recommendations from the CDC, USPSTF, IDSA, AAD, AUA, and ACOG, and revised when guidance changes. The review date on each guide reflects the most recent check. Errors are corrected under the corrections policy.
No. The guides explain how a physician thinks about common conditions so you can make better decisions about care. They do not replace an evaluation by a clinician who knows your history.
Many of the conditions covered can be evaluated by video, and the guides say plainly when a condition needs an in-person exam, labs, or imaging instead. TeleDirectMD visits are $79 flat fee in 40+ states, with insurance accepted in select states. See what we treat.
No. There is no sponsored content and there are no affiliate links. Reviews of at-home tests are independent, and no manufacturer sees a review before it is published.